Emergency Contraceptive Pill
Ulipristal Acetate is an orally-active synthetic SPRM that acts via high-affinity binding to the human progesterone receptor. The primary mechanism of action is inhibition or delay of ovulation. Data shows that even when taken immediately before ovulation is scheduled to occur, Ulipristal Acetate is able to postpone follicular rupture in some women.
Once daily for 3 months; The dose can be repeated with a gap of 4weeks
Ulipristal Acetate interacts with the following drugs: Barbiturates, Carbamazepine, Phenobarbital, Rifampicin, Itraconazole, Ketoconazole etc.
Hypersensitivity to the active substance or to any of the excipients. Genital bleeding of unknown aetiology or for reasons other than uterine fibroids Uterine, cervical, ovarian or breast cancer
Endometrial thickening, Hot flush, Headache, Uterine haemorrhage
Pregnancy Category X. Ulipristal acetate is contraindicated during pregnancy. Ulipristal acetate is excreted in human milk and is not recommended.
Experience with Ulipristal Acetate overdose is limited, in a clinical study, a single dose equivalent to four times Ulipristal Acetate was administered to a limited number of subjects without any adverse reactions.
Store in a dry and cool place, protected from sunlight. Do not freeze. Keep out of reach of children.
.png&w=384&q=75)